Viewing data from:

SUMATRIPTAN

ANDA

SUMATRIPTAN | A213465 | PADAGIS ISRAEL PHARMACEUTICALS LTD

2 strengths0 unique patents0 unique exclusivities

Reference Listed Drug: IMITREX(TE code: AB)

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-10-21 | 2 NDCs

Highest NADAC/Unit

$18.05

per ea

Lowest NADAC/Unit

$15.63

per ea

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
45802061906SUMATRIPTAN 5 MG NASAL SPRAY	$18.05	EA	Generic	—	2026-10-21
45802059806SUMATRIPTAN 20 MG NASAL SPRAY	$15.63	EA	Generic	—	2026-10-21

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$61.11

Highest Price

$162.00

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
45802-0619-06SUMATRIPTAN 5MG/SPRAY SOLN,NASAL,0.1ML	$61.11	FSS	Padagis Sourcing Solutions LLC	09/30/2026
45802-0598-06SUMATRIPTAN 20MG/SPRAY SOLN,NASAL,0.1ML	$162.00	FSS	First Nation Group, LLC	09/14/2029

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain3 active DMFs4 inactive

3 active API suppliers hold Drug Master Files for this ingredient.

SMS PHARMACEUTICALS LTDSUMATRIPTAN USP (ALTERNATIVE SYNTHESIS)

DMF 209062007

MSN PHARMACHEM PRIVATE LTDSUMATRIPTAN USP [ROUTE CODE - "SN"]

DMF 234422010

MOEHS IBERICA SLSUMATRIPTAN

DMF 240262010

QUIMICA SINTETICA SAInactiveSUMATRIPTAN

DMF 169032003

SMS PHARMACEUTICALS LTDInactiveSUMATRIPTAN USP

DMF 182872005

NATCO PHARMA LTDInactiveSUMATRIPTAN

DMF 192122006

HOVIONE FARMACIENCIA SAInactiveSUMATRIPTAN USP

DMF 246422011

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (2)

Sort:

#001 — 20MG/SPRAY

0 patents0 exclusivities▴

SPRAY;NASAL | Approved: Sep 21, 2020

No patent or exclusivity listings for this strength.

#002 — 5MG/SPRAY

0 patents0 exclusivities▾

SPRAY;NASAL | Approved: Sep 21, 2020